133 related articles for article (PubMed ID: 29394673)
21. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
[TBL] [Abstract][Full Text] [Related]
22. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
23. Long-term administration of low-dose cisplatin plus 5-fluorouracil prolongs the postoperative survival of patients with esophageal cancer.
Shiozaki A; Yamagishi H; Itoi H; Fujiwara H; Kikuchi S; Okamoto K; Ichikawa D; Fuji N; Ochiai T; Sonoyama T; Ueda Y
Oncol Rep; 2005 Apr; 13(4):667-72. PubMed ID: 15756440
[TBL] [Abstract][Full Text] [Related]
24. [Complete recovery obtained with combined S-1 + CDDP therapy in a patient with multiple lung metastases from esophageal cancer].
Takada J; Okuda K; Tani C; Kenno S; Oguro S; Shimokuni T; Aoki T; Nagaoka Y; Uno Y; Hamada H
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1967-9. PubMed ID: 18219867
[TBL] [Abstract][Full Text] [Related]
25. Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.
Tanaka T; Fujita H; Sueyoshi S; Tanaka Y; Sasahara H; Mori N; Nagano T; Yamana H; Shirouzu K
Chemotherapy; 2007; 53(6):449-53. PubMed ID: 17952006
[TBL] [Abstract][Full Text] [Related]
26. [A case of reversible encephalopathy syndrome caused by hyponatremia during neoadjuvant 5-FU+CDDP therapy for esophageal cancer].
Kobayashi Y; Nozaki I; Hato S; Kobatake T; Ohta K; Kubo Y; Tanada M; Kurita A
Gan To Kagaku Ryoho; 2013 Mar; 40(3):379-81. PubMed ID: 23507603
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection with and without chemotherapy in oesophageal cancer.
Chander S
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
[No Abstract] [Full Text] [Related]
28. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of docetaxel and nedaplatin combined with concurrent intensity modulated radiation therapy in the treatment of esophageal cancer].
Bi LW; Zhang LZ; Zhao HF
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):710-1. PubMed ID: 23159088
[No Abstract] [Full Text] [Related]
30. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer.
Watanabe M; Nagai Y; Kinoshita K; Saito S; Kurashige J; Karashima R; Hirashima K; Sato N; Imamura Y; Hiyoshi Y; Baba Y; Iwagami S; Miyamoto Y; Iwatsuki M; Hayashi N; Baba H
Digestion; 2011; 83(3):146-52. PubMed ID: 21266808
[TBL] [Abstract][Full Text] [Related]
31. [Postoperative adjuvant therapies for esophageal carcinoma].
Kuwano H; Ojima H; Kato H
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
[TBL] [Abstract][Full Text] [Related]
32. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
Ando N; Kato H; Igaki H; Shinoda M; Ozawa S; Shimizu H; Nakamura T; Yabusaki H; Aoyama N; Kurita A; Ikeda K; Kanda T; Tsujinaka T; Nakamura K; Fukuda H
Ann Surg Oncol; 2012 Jan; 19(1):68-74. PubMed ID: 21879261
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
34. [A Case of Neuroendocrine Carcinoma of the Esophagus Treated with Neoadjuvant Chemotherapy Comprising 5-Fluorouracil plus Cisplatin].
Muroya T; Wajima N; Akasaka H; Hasebe T; Yakoshi Y; Yachi T; Akaishi T; Sato K; Mitsuhashi Y; Hakamada K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2184-2186. PubMed ID: 28133263
[TBL] [Abstract][Full Text] [Related]
35. [A case of primary esophageal carcinoma treated with 5-fluorouracil plus cisplatin and curatively resected after complete response].
Iwasaki K; Ogata T; Fujikawa H; Shirai J; Cho H; Yoshikawa T; Ohta Y; Tachibana S; Oosaka Y; Tsuchida A
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2146-8. PubMed ID: 24394041
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
37. The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy.
Asaka S; Shimakawa T; Yamaguchi K; Murayama M; Shimazaki A; Katsube T; Naritaka Y
Anticancer Res; 2016 Nov; 36(11):6165-6171. PubMed ID: 27793947
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection with and without chemotherapy in oesophageal cancer.
Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
[No Abstract] [Full Text] [Related]
39. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.
Wang J; Xu R; Li J; Bai Y; Liu T; Jiao S; Dai G; Xu J; Liu Y; Fan N; Shu Y; Ba Y; Ma D; Qin S; Zheng L; Chen W; Shen L
Gastric Cancer; 2016 Jan; 19(1):234-44. PubMed ID: 25604851
[TBL] [Abstract][Full Text] [Related]
40. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
